Back

Berberine signature and cardiometabolic diseases: a study leveraging randomized controlled trial, cohort study and Mendelian randomization

29 August 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Cardiometabolic diseases (1) Nutrition, Malnutrition and Heart Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Jie Zhao

The University of Hong Kong, Hong Kong (Hong Kong)

7 More presentations in this session

Presentation thumbnail
Comparison of nutritional risk scores for predicting cardiovascular morbidity and mortality in incident haemodialysis patients
Assistant Professor H. Takahashi (Toyoake, JP)
Abstract Slides Video
Presentation thumbnail
Cardiovascular disease burden attributable to decreased estimated glomerular filtration rate: insights from the ATTICA study (2002-2022)
Miss E. Damigou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Impact of cardiometabolic index on cardiovascular-kidney-metabolic syndrome stage progression: a nationwide prospective cohort study
Miss S. Wu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Impact of body mass index and prediabetes on the risk of type 2 diabetes and cardiovascular events following a recent myocardial infarction
Doctor P. Tonnesen (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Associations of metabolic vulnerability index with cardiometabolic diseases, multimorbidity, and all-cause mortality
Doctor S. Zhu (Hangzhou, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiometabolic diseases (1)

The Event

Event poster

ESC Congress 2025

29 August 2025 14:15 CET
You may be interested in
thumbnail
Congress Session
Repurposing anti-diabetic pharmacotherapy: the new cure for all evils?
2 September 2024
thumbnail
Congress Presentation
A comprehensive analysis of 30 Biomarkers and their association with cardiovascular outcomes and mortality in the UK Biobank
26 August 2023
thumbnail
Congress Presentation
Evaluating off-target drug effects seen in RCTs using proteomics and mendelian randomisation
1 September 2024
thumbnail
Congress Presentation
BET protein inhibition rewires the vascular-fat interface in cardiometabolic disease
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources